| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Thoracic Surgery | 27 | 2022 | 295 | 8.060 |
Why?
|
| Heart Valve Prosthesis Implantation | 50 | 2023 | 563 | 6.220 |
Why?
|
| Cardiac Surgical Procedures | 38 | 2023 | 1237 | 4.580 |
Why?
|
| Aortic Aneurysm, Thoracic | 20 | 2024 | 595 | 3.270 |
Why?
|
| Thoracic Surgical Procedures | 12 | 2022 | 261 | 3.230 |
Why?
|
| Heart Valve Diseases | 20 | 2022 | 193 | 3.160 |
Why?
|
| Atrial Fibrillation | 28 | 2023 | 719 | 2.970 |
Why?
|
| Blood Vessel Prosthesis Implantation | 18 | 2024 | 705 | 2.830 |
Why?
|
| Coronary Artery Bypass | 29 | 2023 | 708 | 2.740 |
Why?
|
| Surgeons | 11 | 2023 | 519 | 2.710 |
Why?
|
| Aortic Valve | 27 | 2023 | 581 | 2.450 |
Why?
|
| Mitral Valve | 21 | 2022 | 271 | 2.440 |
Why?
|
| Aortic Valve Stenosis | 21 | 2022 | 476 | 2.310 |
Why?
|
| Cardiac Catheterization | 24 | 2015 | 687 | 2.210 |
Why?
|
| Societies, Medical | 14 | 2022 | 1335 | 2.140 |
Why?
|
| Bioprosthesis | 14 | 2023 | 167 | 2.040 |
Why?
|
| Aorta, Thoracic | 15 | 2024 | 546 | 1.970 |
Why?
|
| Heart Valve Prosthesis | 15 | 2022 | 386 | 1.940 |
Why?
|
| Ventricular Function, Right | 10 | 2012 | 111 | 1.920 |
Why?
|
| Aortic Aneurysm | 13 | 2021 | 230 | 1.870 |
Why?
|
| Mitral Valve Insufficiency | 11 | 2022 | 180 | 1.850 |
Why?
|
| Education, Medical, Graduate | 10 | 2021 | 671 | 1.840 |
Why?
|
| Marfan Syndrome | 4 | 2019 | 142 | 1.820 |
Why?
|
| Internship and Residency | 8 | 2022 | 1375 | 1.640 |
Why?
|
| Specialties, Surgical | 4 | 2022 | 137 | 1.630 |
Why?
|
| Certification | 4 | 2022 | 123 | 1.610 |
Why?
|
| Myocardial Revascularization | 8 | 2021 | 134 | 1.590 |
Why?
|
| Hypertension, Pulmonary | 8 | 2015 | 462 | 1.560 |
Why?
|
| Coronary Artery Disease | 10 | 2023 | 1011 | 1.490 |
Why?
|
| Clinical Competence | 17 | 2023 | 1270 | 1.470 |
Why?
|
| Myocardial Ischemia | 9 | 2023 | 435 | 1.450 |
Why?
|
| Endovascular Procedures | 7 | 2024 | 516 | 1.420 |
Why?
|
| Cardiology | 10 | 2021 | 530 | 1.370 |
Why?
|
| Aortic Diseases | 11 | 2023 | 206 | 1.310 |
Why?
|
| Aortic Valve Insufficiency | 7 | 2022 | 167 | 1.220 |
Why?
|
| Atrial Function, Right | 5 | 2012 | 8 | 1.190 |
Why?
|
| Ventricular Function, Left | 17 | 2021 | 603 | 1.180 |
Why?
|
| Catheter Ablation | 18 | 2021 | 620 | 1.170 |
Why?
|
| Reoperation | 13 | 2022 | 1382 | 1.130 |
Why?
|
| Humans | 226 | 2024 | 261506 | 1.120 |
Why?
|
| Ventricular Pressure | 5 | 2012 | 46 | 1.090 |
Why?
|
| Hemodynamics | 15 | 2018 | 935 | 1.070 |
Why?
|
| History, 20th Century | 10 | 2017 | 574 | 1.060 |
Why?
|
| Heart Diseases | 10 | 2023 | 732 | 1.050 |
Why?
|
| Endocarditis | 4 | 2024 | 125 | 1.040 |
Why?
|
| Specialty Boards | 2 | 2022 | 46 | 1.020 |
Why?
|
| Postoperative Complications | 33 | 2023 | 5542 | 1.000 |
Why?
|
| Vascular Surgical Procedures | 11 | 2021 | 655 | 1.000 |
Why?
|
| Ventricular Dysfunction, Right | 4 | 2012 | 74 | 0.960 |
Why?
|
| Blood Vessel Prosthesis | 11 | 2020 | 412 | 0.930 |
Why?
|
| Treatment Outcome | 77 | 2024 | 32848 | 0.920 |
Why?
|
| Periodicals as Topic | 3 | 2017 | 338 | 0.910 |
Why?
|
| Jehovah's Witnesses | 1 | 2022 | 21 | 0.880 |
Why?
|
| Heart-Assist Devices | 12 | 2021 | 1171 | 0.830 |
Why?
|
| Missouri | 12 | 2018 | 49 | 0.830 |
Why?
|
| History, 21st Century | 7 | 2017 | 441 | 0.820 |
Why?
|
| Mitral Valve Annuloplasty | 3 | 2021 | 22 | 0.800 |
Why?
|
| Heart Atria | 9 | 2020 | 352 | 0.800 |
Why?
|
| Dogs | 23 | 2012 | 1155 | 0.790 |
Why?
|
| Arterial Pressure | 2 | 2019 | 107 | 0.790 |
Why?
|
| Heart Ventricles | 8 | 2021 | 846 | 0.740 |
Why?
|
| Coronavirus | 1 | 2020 | 40 | 0.720 |
Why?
|
| Sexual Harassment | 1 | 2019 | 22 | 0.720 |
Why?
|
| Retrospective Studies | 75 | 2023 | 37905 | 0.720 |
Why?
|
| Percutaneous Coronary Intervention | 2 | 2023 | 342 | 0.720 |
Why?
|
| Heart Transplantation | 10 | 2023 | 908 | 0.710 |
Why?
|
| Career Choice | 2 | 2022 | 232 | 0.700 |
Why?
|
| Risk Factors | 42 | 2023 | 17523 | 0.700 |
Why?
|
| United States | 27 | 2023 | 15433 | 0.700 |
Why?
|
| Hemofiltration | 1 | 2019 | 20 | 0.700 |
Why?
|
| Risk Assessment | 32 | 2023 | 6869 | 0.690 |
Why?
|
| Learning Curve | 4 | 2021 | 68 | 0.680 |
Why?
|
| Stents | 8 | 2020 | 1096 | 0.680 |
Why?
|
| Heart | 6 | 2022 | 1223 | 0.660 |
Why?
|
| Male | 133 | 2023 | 123000 | 0.660 |
Why?
|
| Cardiac Valve Annuloplasty | 1 | 2018 | 11 | 0.650 |
Why?
|
| Minority Groups | 1 | 2020 | 322 | 0.640 |
Why?
|
| Educational Measurement | 3 | 2015 | 362 | 0.630 |
Why?
|
| White Matter | 1 | 2020 | 195 | 0.610 |
Why?
|
| Female | 129 | 2022 | 141928 | 0.590 |
Why?
|
| Clinical Decision-Making | 4 | 2021 | 524 | 0.590 |
Why?
|
| Laser Therapy | 4 | 2006 | 411 | 0.590 |
Why?
|
| Anemia | 1 | 2022 | 689 | 0.580 |
Why?
|
| Transcatheter Aortic Valve Replacement | 5 | 2022 | 314 | 0.580 |
Why?
|
| Stroke | 4 | 2023 | 1144 | 0.580 |
Why?
|
| Heart Failure | 9 | 2021 | 2516 | 0.570 |
Why?
|
| Hospitals | 7 | 2023 | 485 | 0.560 |
Why?
|
| Patient Care Team | 11 | 2021 | 795 | 0.560 |
Why?
|
| Forecasting | 2 | 2018 | 694 | 0.550 |
Why?
|
| Aortic Rupture | 5 | 2012 | 113 | 0.540 |
Why?
|
| Aged | 89 | 2023 | 70117 | 0.520 |
Why?
|
| Coronavirus Infections | 2 | 2020 | 651 | 0.520 |
Why?
|
| Task Performance and Analysis | 2 | 2015 | 136 | 0.520 |
Why?
|
| Pneumonia, Viral | 2 | 2020 | 715 | 0.510 |
Why?
|
| Aged, 80 and over | 51 | 2020 | 29902 | 0.510 |
Why?
|
| Middle Aged | 90 | 2023 | 86204 | 0.510 |
Why?
|
| Academic Medical Centers | 3 | 2020 | 672 | 0.510 |
Why?
|
| Pandemics | 3 | 2021 | 1559 | 0.500 |
Why?
|
| Acute Kidney Injury | 1 | 2022 | 739 | 0.500 |
Why?
|
| Vascular Neoplasms | 2 | 2014 | 114 | 0.500 |
Why?
|
| Cardiac Output | 5 | 2012 | 194 | 0.480 |
Why?
|
| Radial Artery | 4 | 2012 | 50 | 0.470 |
Why?
|
| Dissection | 2 | 2024 | 156 | 0.470 |
Why?
|
| Sternotomy | 1 | 2014 | 58 | 0.470 |
Why?
|
| Brain Injuries | 1 | 2020 | 787 | 0.460 |
Why?
|
| Curriculum | 2 | 2018 | 860 | 0.460 |
Why?
|
| Time Factors | 31 | 2020 | 12926 | 0.460 |
Why?
|
| Prosthesis-Related Infections | 3 | 2006 | 232 | 0.460 |
Why?
|
| Endocarditis, Bacterial | 3 | 2007 | 128 | 0.450 |
Why?
|
| Myocardial Contraction | 9 | 2012 | 291 | 0.440 |
Why?
|
| Ostomy | 1 | 2012 | 19 | 0.440 |
Why?
|
| Pulmonary Valve | 5 | 2015 | 87 | 0.440 |
Why?
|
| Military Medicine | 1 | 2013 | 53 | 0.440 |
Why?
|
| Cryosurgery | 4 | 2017 | 167 | 0.430 |
Why?
|
| Coronary Disease | 7 | 2017 | 764 | 0.430 |
Why?
|
| Thoracotomy | 1 | 2014 | 220 | 0.430 |
Why?
|
| Vena Cava, Superior | 1 | 2012 | 78 | 0.430 |
Why?
|
| Education, Medical, Undergraduate | 1 | 2014 | 191 | 0.420 |
Why?
|
| Follow-Up Studies | 30 | 2020 | 14889 | 0.420 |
Why?
|
| Faculty, Medical | 1 | 2014 | 289 | 0.410 |
Why?
|
| Angioplasty | 2 | 2009 | 94 | 0.400 |
Why?
|
| Anticoagulants | 5 | 2023 | 787 | 0.400 |
Why?
|
| Multivariate Analysis | 18 | 2016 | 4298 | 0.390 |
Why?
|
| Coronary Circulation | 4 | 2009 | 253 | 0.390 |
Why?
|
| Tuberculosis, Pulmonary | 1 | 2013 | 247 | 0.380 |
Why?
|
| Health Status Indicators | 2 | 2012 | 224 | 0.380 |
Why?
|
| Device Removal | 3 | 2008 | 337 | 0.370 |
Why?
|
| Survival Analysis | 19 | 2018 | 9180 | 0.370 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2012 | 323 | 0.370 |
Why?
|
| Adult | 55 | 2022 | 77950 | 0.370 |
Why?
|
| Coronary Vessels | 1 | 2014 | 665 | 0.360 |
Why?
|
| Physicians, Women | 2 | 2022 | 105 | 0.360 |
Why?
|
| Attitude of Health Personnel | 4 | 2021 | 918 | 0.360 |
Why?
|
| Patient Selection | 10 | 2021 | 2055 | 0.360 |
Why?
|
| American Heart Association | 6 | 2023 | 310 | 0.350 |
Why?
|
| Defibrillators, Implantable | 4 | 2007 | 221 | 0.350 |
Why?
|
| Electrodes, Implanted | 2 | 2006 | 183 | 0.340 |
Why?
|
| Cooperative Behavior | 2 | 2021 | 313 | 0.330 |
Why?
|
| Calcium Channel Blockers | 1 | 2009 | 135 | 0.330 |
Why?
|
| Mentors | 2 | 2021 | 203 | 0.330 |
Why?
|
| Systole | 8 | 1999 | 196 | 0.320 |
Why?
|
| Chordae Tendineae | 3 | 1999 | 8 | 0.320 |
Why?
|
| Adaptation, Physiological | 2 | 2011 | 360 | 0.320 |
Why?
|
| Pacemaker, Artificial | 4 | 2013 | 213 | 0.320 |
Why?
|
| Aorta | 5 | 2018 | 692 | 0.320 |
Why?
|
| Stroke Volume | 6 | 2021 | 577 | 0.310 |
Why?
|
| Diffusion of Innovation | 3 | 2017 | 160 | 0.300 |
Why?
|
| Survival Rate | 20 | 2021 | 12221 | 0.290 |
Why?
|
| Extracorporeal Membrane Oxygenation | 3 | 2021 | 581 | 0.280 |
Why?
|
| Severity of Illness Index | 11 | 2018 | 4320 | 0.280 |
Why?
|
| Hand | 2 | 2023 | 170 | 0.280 |
Why?
|
| Hypertension | 3 | 2012 | 1503 | 0.280 |
Why?
|
| Acute Disease | 7 | 2021 | 2422 | 0.280 |
Why?
|
| Hospital Mortality | 6 | 2020 | 1274 | 0.280 |
Why?
|
| Heart Valves | 2 | 2018 | 66 | 0.270 |
Why?
|
| Age Factors | 13 | 2020 | 5377 | 0.270 |
Why?
|
| Body Size | 1 | 2006 | 70 | 0.270 |
Why?
|
| Calcium | 1 | 2012 | 1537 | 0.270 |
Why?
|
| Sarcoma | 2 | 2014 | 1725 | 0.260 |
Why?
|
| Radial Neuropathy | 1 | 2004 | 2 | 0.250 |
Why?
|
| Diathermy | 1 | 2004 | 8 | 0.250 |
Why?
|
| Median Nerve | 1 | 2004 | 24 | 0.250 |
Why?
|
| Paresthesia | 1 | 2004 | 33 | 0.250 |
Why?
|
| Angiography | 3 | 2018 | 360 | 0.250 |
Why?
|
| Hypesthesia | 1 | 2004 | 22 | 0.250 |
Why?
|
| Echocardiography | 8 | 2020 | 1182 | 0.250 |
Why?
|
| Catheterization, Peripheral | 3 | 2015 | 158 | 0.250 |
Why?
|
| Cardiovascular Infections | 1 | 2024 | 7 | 0.250 |
Why?
|
| Ventricular Dysfunction, Left | 4 | 2015 | 435 | 0.240 |
Why?
|
| Perfusion | 3 | 2015 | 293 | 0.240 |
Why?
|
| Cardiomyopathies | 2 | 2021 | 610 | 0.240 |
Why?
|
| Enoxaparin | 2 | 2005 | 66 | 0.240 |
Why?
|
| Disease Models, Animal | 7 | 2015 | 7222 | 0.230 |
Why?
|
| Pulmonary Artery | 5 | 2011 | 499 | 0.230 |
Why?
|
| Streptococcus sanguis | 1 | 2003 | 1 | 0.230 |
Why?
|
| Streptococcus mitis | 1 | 2003 | 4 | 0.230 |
Why?
|
| Practice Guidelines as Topic | 3 | 2021 | 2403 | 0.230 |
Why?
|
| Evidence-Based Medicine | 6 | 2016 | 1085 | 0.230 |
Why?
|
| Tissue and Organ Harvesting | 1 | 2004 | 148 | 0.220 |
Why?
|
| Machine Learning | 2 | 2022 | 319 | 0.220 |
Why?
|
| Animals | 32 | 2020 | 59536 | 0.220 |
Why?
|
| Shock, Cardiogenic | 2 | 2021 | 228 | 0.220 |
Why?
|
| Atrial Function, Left | 4 | 2020 | 24 | 0.220 |
Why?
|
| Postoperative Hemorrhage | 2 | 2005 | 162 | 0.210 |
Why?
|
| Heart Rate | 5 | 2020 | 737 | 0.210 |
Why?
|
| Blood Coagulation | 2 | 2023 | 185 | 0.210 |
Why?
|
| Familial Primary Pulmonary Hypertension | 2 | 2012 | 21 | 0.210 |
Why?
|
| Propensity Score | 3 | 2020 | 750 | 0.210 |
Why?
|
| Combined Modality Therapy | 8 | 2021 | 8865 | 0.210 |
Why?
|
| Anastomosis, Surgical | 5 | 2023 | 371 | 0.210 |
Why?
|
| Health Knowledge, Attitudes, Practice | 2 | 2021 | 1209 | 0.210 |
Why?
|
| Quality of Life | 3 | 2006 | 4532 | 0.210 |
Why?
|
| Cause of Death | 4 | 2016 | 752 | 0.210 |
Why?
|
| I-kappa B Proteins | 2 | 2000 | 170 | 0.210 |
Why?
|
| Cultural Diversity | 1 | 2022 | 76 | 0.200 |
Why?
|
| Chi-Square Distribution | 6 | 2015 | 1323 | 0.200 |
Why?
|
| Interleukin-1 | 3 | 2000 | 461 | 0.200 |
Why?
|
| Prosthesis Design | 8 | 2023 | 749 | 0.200 |
Why?
|
| Anger | 1 | 2021 | 21 | 0.200 |
Why?
|
| Catheterization | 3 | 2021 | 410 | 0.200 |
Why?
|
| Ischemia | 3 | 2017 | 391 | 0.200 |
Why?
|
| Leadership | 2 | 2021 | 254 | 0.200 |
Why?
|
| Kaplan-Meier Estimate | 13 | 2016 | 6207 | 0.200 |
Why?
|
| Medicine | 1 | 2023 | 137 | 0.200 |
Why?
|
| Secondary Prevention | 1 | 2023 | 329 | 0.190 |
Why?
|
| Child Advocacy | 1 | 2000 | 8 | 0.190 |
Why?
|
| Recurrence | 10 | 2020 | 4758 | 0.190 |
Why?
|
| Bronchial Fistula | 1 | 2020 | 37 | 0.190 |
Why?
|
| Intra-Aortic Balloon Pumping | 1 | 2021 | 69 | 0.190 |
Why?
|
| Long Term Adverse Effects | 1 | 2020 | 23 | 0.190 |
Why?
|
| Cardiac Pacing, Artificial | 3 | 2013 | 127 | 0.190 |
Why?
|
| Surge Capacity | 1 | 2020 | 9 | 0.190 |
Why?
|
| Vascular Fistula | 1 | 2020 | 41 | 0.190 |
Why?
|
| Creatinine | 1 | 2022 | 531 | 0.190 |
Why?
|
| Women | 1 | 2020 | 27 | 0.180 |
Why?
|
| Streptococcal Infections | 1 | 2003 | 280 | 0.180 |
Why?
|
| Femoral Artery | 3 | 2015 | 210 | 0.180 |
Why?
|
| Length of Stay | 12 | 2021 | 1900 | 0.180 |
Why?
|
| Natriuretic Peptide, Brain | 3 | 2015 | 343 | 0.180 |
Why?
|
| Heart Septum | 2 | 1997 | 54 | 0.180 |
Why?
|
| Vascular Patency | 4 | 2012 | 218 | 0.180 |
Why?
|
| Education, Medical | 2 | 2014 | 331 | 0.170 |
Why?
|
| Cardiopulmonary Bypass | 7 | 2015 | 422 | 0.170 |
Why?
|
| Hospital Costs | 1 | 2021 | 228 | 0.170 |
Why?
|
| Chondroitin Sulfates | 2 | 2014 | 21 | 0.170 |
Why?
|
| Blood Transfusion | 1 | 2022 | 583 | 0.170 |
Why?
|
| Time Perception | 1 | 2018 | 13 | 0.170 |
Why?
|
| Lidocaine | 1 | 1999 | 76 | 0.170 |
Why?
|
| Analgesia, Patient-Controlled | 1 | 1999 | 59 | 0.170 |
Why?
|
| Administration, Oral | 1 | 2023 | 1544 | 0.170 |
Why?
|
| Thoracic Injuries | 1 | 1999 | 58 | 0.170 |
Why?
|
| Complement C3 | 1 | 1999 | 78 | 0.170 |
Why?
|
| Myocardial Infarction | 4 | 2014 | 1374 | 0.170 |
Why?
|
| Antifibrinolytic Agents | 1 | 1999 | 68 | 0.160 |
Why?
|
| Constriction | 4 | 2015 | 55 | 0.160 |
Why?
|
| Logistic Models | 10 | 2017 | 3441 | 0.160 |
Why?
|
| Self Concept | 1 | 2020 | 211 | 0.160 |
Why?
|
| Blood Pressure | 5 | 2012 | 1467 | 0.160 |
Why?
|
| Chronic Disease | 3 | 2009 | 1819 | 0.160 |
Why?
|
| Surface-Active Agents | 1 | 2018 | 41 | 0.160 |
Why?
|
| Incidence | 9 | 2023 | 5673 | 0.160 |
Why?
|
| Analgesia, Epidural | 1 | 1999 | 102 | 0.160 |
Why?
|
| Transposition of Great Vessels | 1 | 2019 | 124 | 0.160 |
Why?
|
| Tomography | 1 | 2018 | 55 | 0.160 |
Why?
|
| Heart Conduction System | 1 | 2019 | 165 | 0.160 |
Why?
|
| Medical Errors | 1 | 2020 | 219 | 0.160 |
Why?
|
| Tyrosine | 1 | 1999 | 498 | 0.160 |
Why?
|
| Betacoronavirus | 2 | 2020 | 527 | 0.160 |
Why?
|
| Anesthesiologists | 1 | 2018 | 49 | 0.160 |
Why?
|
| Suture Techniques | 3 | 2018 | 319 | 0.160 |
Why?
|
| Compliance | 2 | 2009 | 16 | 0.150 |
Why?
|
| Progesterone | 1 | 2020 | 513 | 0.150 |
Why?
|
| Patient Readmission | 3 | 2023 | 548 | 0.150 |
Why?
|
| Predictive Value of Tests | 8 | 2017 | 4892 | 0.150 |
Why?
|
| Preoperative Care | 3 | 2020 | 1529 | 0.150 |
Why?
|
| Diagnostic Imaging | 4 | 2018 | 1162 | 0.150 |
Why?
|
| Hypoxia | 1 | 2020 | 443 | 0.150 |
Why?
|
| Risk Adjustment | 1 | 2017 | 83 | 0.150 |
Why?
|
| Morphine | 1 | 1999 | 308 | 0.150 |
Why?
|
| Heparin | 3 | 2014 | 360 | 0.150 |
Why?
|
| Hemostatics | 1 | 2018 | 88 | 0.150 |
Why?
|
| Probability | 6 | 2009 | 866 | 0.150 |
Why?
|
| Staphylococcal Infections | 1 | 2003 | 672 | 0.150 |
Why?
|
| Hemoglobins | 1 | 2019 | 477 | 0.150 |
Why?
|
| Cardiac Care Facilities | 1 | 2016 | 11 | 0.150 |
Why?
|
| Ethics, Medical | 1 | 2000 | 442 | 0.150 |
Why?
|
| Graft Rejection | 2 | 2020 | 834 | 0.150 |
Why?
|
| Analysis of Variance | 5 | 2012 | 2307 | 0.140 |
Why?
|
| Consensus | 4 | 2024 | 978 | 0.140 |
Why?
|
| Acidosis | 1 | 2017 | 116 | 0.140 |
Why?
|
| Students, Medical | 1 | 2022 | 399 | 0.140 |
Why?
|
| Oxygen | 2 | 2012 | 754 | 0.140 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2014 | 5319 | 0.140 |
Why?
|
| Medical Staff Privileges | 5 | 2014 | 10 | 0.140 |
Why?
|
| Ontario | 1 | 2016 | 98 | 0.140 |
Why?
|
| Aorta, Abdominal | 1 | 1997 | 152 | 0.140 |
Why?
|
| Lung Diseases | 3 | 2015 | 717 | 0.140 |
Why?
|
| Magnesium | 1 | 2016 | 160 | 0.140 |
Why?
|
| Anniversaries and Special Events | 1 | 2015 | 23 | 0.140 |
Why?
|
| Smoking Prevention | 1 | 2016 | 138 | 0.140 |
Why?
|
| Animals, Newborn | 1 | 2020 | 1338 | 0.140 |
Why?
|
| Proportional Hazards Models | 8 | 2020 | 4988 | 0.140 |
Why?
|
| Loeys-Dietz Syndrome | 1 | 2016 | 37 | 0.140 |
Why?
|
| Blood Loss, Surgical | 1 | 2018 | 309 | 0.140 |
Why?
|
| Competitive Behavior | 1 | 2015 | 17 | 0.130 |
Why?
|
| Abdomen | 1 | 2017 | 332 | 0.130 |
Why?
|
| Kidney Failure, Chronic | 2 | 2018 | 960 | 0.130 |
Why?
|
| Diastole | 7 | 1997 | 187 | 0.130 |
Why?
|
| Growth Differentiation Factor 15 | 1 | 2015 | 24 | 0.130 |
Why?
|
| Potassium | 1 | 2016 | 329 | 0.130 |
Why?
|
| NF-kappa B | 2 | 2000 | 1549 | 0.130 |
Why?
|
| Substance Abuse, Intravenous | 2 | 2007 | 42 | 0.130 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2018 | 624 | 0.130 |
Why?
|
| Comorbidity | 5 | 2015 | 2352 | 0.130 |
Why?
|
| Pulmonary Valve Insufficiency | 1 | 2015 | 34 | 0.130 |
Why?
|
| Pulmonary Valve Stenosis | 1 | 2015 | 44 | 0.130 |
Why?
|
| Stress, Mechanical | 4 | 2011 | 311 | 0.130 |
Why?
|
| Calcinosis | 1 | 1998 | 423 | 0.130 |
Why?
|
| Tissue Preservation | 1 | 1994 | 30 | 0.130 |
Why?
|
| Health Personnel | 1 | 2020 | 625 | 0.130 |
Why?
|
| Drug Contamination | 1 | 2014 | 52 | 0.120 |
Why?
|
| Accreditation | 1 | 2015 | 126 | 0.120 |
Why?
|
| Respiratory Function Tests | 1 | 2015 | 318 | 0.120 |
Why?
|
| Polyethylene Glycols | 1 | 2018 | 615 | 0.120 |
Why?
|
| Health Facilities | 1 | 2014 | 79 | 0.120 |
Why?
|
| Renal Dialysis | 2 | 2018 | 945 | 0.120 |
Why?
|
| Ablation Techniques | 1 | 2015 | 148 | 0.120 |
Why?
|
| Systemic Inflammatory Response Syndrome | 1 | 2015 | 182 | 0.110 |
Why?
|
| Coronary Angiography | 3 | 2013 | 598 | 0.110 |
Why?
|
| Teaching | 1 | 2015 | 243 | 0.110 |
Why?
|
| Electrocardiography | 6 | 2019 | 1145 | 0.110 |
Why?
|
| Anti-Arrhythmia Agents | 5 | 2017 | 226 | 0.110 |
Why?
|
| Pilot Projects | 2 | 2019 | 2803 | 0.110 |
Why?
|
| Delirium | 1 | 2015 | 207 | 0.110 |
Why?
|
| Myocardium | 2 | 2019 | 1313 | 0.110 |
Why?
|
| Aortic Aneurysm, Abdominal | 3 | 2003 | 384 | 0.110 |
Why?
|
| Abnormalities, Multiple | 1 | 2019 | 998 | 0.110 |
Why?
|
| Monocrotaline | 1 | 2012 | 3 | 0.110 |
Why?
|
| Models, Cardiovascular | 4 | 2015 | 202 | 0.110 |
Why?
|
| Case-Control Studies | 3 | 2019 | 6100 | 0.110 |
Why?
|
| Sarcoplasmic Reticulum Calcium-Transporting ATPases | 1 | 2012 | 38 | 0.110 |
Why?
|
| Coronary Restenosis | 1 | 2012 | 63 | 0.110 |
Why?
|
| Analgesics, Opioid | 2 | 1999 | 1371 | 0.110 |
Why?
|
| Ischemic Attack, Transient | 1 | 2012 | 55 | 0.110 |
Why?
|
| Knowledge Bases | 4 | 2012 | 41 | 0.110 |
Why?
|
| Circulatory Arrest, Deep Hypothermia Induced | 2 | 2015 | 54 | 0.110 |
Why?
|
| Genetic Testing | 1 | 2000 | 1589 | 0.100 |
Why?
|
| Dietary Supplements | 1 | 2016 | 558 | 0.100 |
Why?
|
| Hypertrophy, Right Ventricular | 1 | 2011 | 14 | 0.100 |
Why?
|
| Heart Arrest, Induced | 2 | 2002 | 87 | 0.100 |
Why?
|
| Stress, Physiological | 1 | 2015 | 492 | 0.100 |
Why?
|
| History, 19th Century | 1 | 2011 | 154 | 0.100 |
Why?
|
| Receptors, Cell Surface | 1 | 2015 | 862 | 0.100 |
Why?
|
| Thromboembolism | 1 | 2012 | 155 | 0.100 |
Why?
|
| Pneumonectomy | 1 | 2016 | 831 | 0.100 |
Why?
|
| Adolescent | 10 | 2018 | 31252 | 0.100 |
Why?
|
| Rats | 1 | 2020 | 6086 | 0.100 |
Why?
|
| Lung Neoplasms | 1 | 2014 | 11538 | 0.100 |
Why?
|
| Warfarin | 1 | 2012 | 152 | 0.100 |
Why?
|
| Pregnancy Complications | 1 | 2016 | 526 | 0.100 |
Why?
|
| Blood Flow Velocity | 1 | 2012 | 475 | 0.100 |
Why?
|
| Smoking Cessation | 1 | 2016 | 712 | 0.100 |
Why?
|
| Tomography, X-Ray Computed | 6 | 2024 | 7551 | 0.100 |
Why?
|
| Sufentanil | 2 | 2001 | 8 | 0.100 |
Why?
|
| Interviews as Topic | 1 | 2012 | 497 | 0.100 |
Why?
|
| Pain | 1 | 1999 | 1658 | 0.090 |
Why?
|
| Delphi Technique | 2 | 2021 | 210 | 0.090 |
Why?
|
| Biomechanical Phenomena | 1 | 2011 | 338 | 0.090 |
Why?
|
| Disease Progression | 4 | 2020 | 6682 | 0.090 |
Why?
|
| Nervous System Diseases | 2 | 2007 | 500 | 0.090 |
Why?
|
| Diabetes Complications | 1 | 2012 | 305 | 0.090 |
Why?
|
| Algorithms | 3 | 2011 | 3890 | 0.090 |
Why?
|
| Anesthetics, Intravenous | 2 | 2001 | 73 | 0.090 |
Why?
|
| Prospective Studies | 11 | 2015 | 12873 | 0.090 |
Why?
|
| Electrocardiography, Ambulatory | 3 | 2017 | 66 | 0.090 |
Why?
|
| Heart Neoplasms | 1 | 2012 | 214 | 0.090 |
Why?
|
| Calcium-Binding Proteins | 1 | 2012 | 545 | 0.090 |
Why?
|
| Pulmonary Veins | 3 | 2008 | 174 | 0.090 |
Why?
|
| Graft Occlusion, Vascular | 2 | 2003 | 118 | 0.090 |
Why?
|
| Peptide Fragments | 1 | 2015 | 1271 | 0.090 |
Why?
|
| Sampling Studies | 1 | 2009 | 170 | 0.090 |
Why?
|
| Electric Countershock | 2 | 2007 | 71 | 0.090 |
Why?
|
| Echocardiography, Transesophageal | 2 | 2003 | 303 | 0.090 |
Why?
|
| Prosthesis Fitting | 1 | 2008 | 16 | 0.090 |
Why?
|
| Equipment Design | 3 | 2007 | 1204 | 0.080 |
Why?
|
| Atrial Function | 1 | 2008 | 18 | 0.080 |
Why?
|
| Elective Surgical Procedures | 2 | 2010 | 250 | 0.080 |
Why?
|
| Brain | 1 | 2002 | 4113 | 0.080 |
Why?
|
| Referral and Consultation | 1 | 2014 | 899 | 0.080 |
Why?
|
| Intestinal Mucosa | 3 | 2000 | 1081 | 0.080 |
Why?
|
| Tricuspid Valve | 1 | 2009 | 68 | 0.080 |
Why?
|
| Magnetic Resonance Imaging, Cine | 2 | 2019 | 136 | 0.080 |
Why?
|
| Pressure | 3 | 2005 | 215 | 0.080 |
Why?
|
| Elasticity | 2 | 2005 | 156 | 0.080 |
Why?
|
| Transplantation, Homologous | 3 | 2006 | 2843 | 0.080 |
Why?
|
| Hematologic Agents | 1 | 2007 | 13 | 0.080 |
Why?
|
| Cardiovascular Surgical Procedures | 2 | 2005 | 53 | 0.080 |
Why?
|
| Aortography | 3 | 2010 | 181 | 0.080 |
Why?
|
| Factor VIIa | 1 | 2007 | 31 | 0.080 |
Why?
|
| Esophagectomy | 1 | 1992 | 911 | 0.080 |
Why?
|
| Sheep | 3 | 2004 | 258 | 0.080 |
Why?
|
| Sex Factors | 4 | 2020 | 2139 | 0.080 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2023 | 5437 | 0.080 |
Why?
|
| Smoking | 1 | 2016 | 2440 | 0.080 |
Why?
|
| Foreign-Body Migration | 1 | 2008 | 117 | 0.070 |
Why?
|
| Quality of Health Care | 4 | 2012 | 621 | 0.070 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2016 | 1303 | 0.070 |
Why?
|
| Skin Neoplasms | 1 | 2023 | 4654 | 0.070 |
Why?
|
| Prosthesis Failure | 1 | 2008 | 206 | 0.070 |
Why?
|
| Cohort Studies | 6 | 2020 | 9244 | 0.070 |
Why?
|
| Swine | 5 | 2015 | 1541 | 0.070 |
Why?
|
| DNA-Binding Proteins | 2 | 2000 | 4821 | 0.070 |
Why?
|
| Thoracic Arteries | 1 | 2006 | 10 | 0.070 |
Why?
|
| Pericardial Effusion | 1 | 2007 | 118 | 0.070 |
Why?
|
| Enterocolitis, Pseudomembranous | 1 | 2007 | 111 | 0.070 |
Why?
|
| Databases, Factual | 3 | 2020 | 2218 | 0.070 |
Why?
|
| Regression Analysis | 2 | 2011 | 1546 | 0.070 |
Why?
|
| Angina, Unstable | 2 | 2003 | 70 | 0.070 |
Why?
|
| Time | 2 | 2017 | 178 | 0.070 |
Why?
|
| Arteriovenous Fistula | 1 | 2006 | 92 | 0.070 |
Why?
|
| Prognosis | 2 | 2018 | 21713 | 0.070 |
Why?
|
| Tourniquets | 1 | 2004 | 14 | 0.070 |
Why?
|
| Ligation | 1 | 2005 | 193 | 0.060 |
Why?
|
| Risk | 2 | 2016 | 1972 | 0.060 |
Why?
|
| Ultrasonics | 1 | 2004 | 69 | 0.060 |
Why?
|
| Thumb | 1 | 2004 | 35 | 0.060 |
Why?
|
| Cardiac Output, Low | 1 | 2004 | 81 | 0.060 |
Why?
|
| Lung | 1 | 2015 | 3151 | 0.060 |
Why?
|
| Waiting Lists | 2 | 2021 | 263 | 0.060 |
Why?
|
| Wounds, Penetrating | 1 | 2004 | 89 | 0.060 |
Why?
|
| Magnetic Resonance Imaging | 5 | 2015 | 7702 | 0.060 |
Why?
|
| Axillary Artery | 1 | 2003 | 33 | 0.060 |
Why?
|
| Brain Diseases | 1 | 2007 | 403 | 0.060 |
Why?
|
| Natriuretic Agents | 1 | 2003 | 31 | 0.060 |
Why?
|
| DNA Glycosylases | 1 | 2003 | 93 | 0.060 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 1 | 2024 | 305 | 0.060 |
Why?
|
| Leiomyosarcoma | 1 | 2004 | 223 | 0.060 |
Why?
|
| Thiocarbamates | 2 | 2000 | 17 | 0.060 |
Why?
|
| Prevalence | 2 | 2013 | 3260 | 0.060 |
Why?
|
| Motion | 1 | 2023 | 193 | 0.050 |
Why?
|
| Paraplegia | 1 | 2003 | 95 | 0.050 |
Why?
|
| Wounds, Nonpenetrating | 1 | 2004 | 176 | 0.050 |
Why?
|
| Hemorrhage | 1 | 2007 | 712 | 0.050 |
Why?
|
| NF-KappaB Inhibitor alpha | 2 | 2000 | 136 | 0.050 |
Why?
|
| Aneurysm, False | 1 | 2004 | 153 | 0.050 |
Why?
|
| Coronary Stenosis | 1 | 2003 | 117 | 0.050 |
Why?
|
| Ultrasonography | 3 | 2015 | 1863 | 0.050 |
Why?
|
| Cross Infection | 1 | 2007 | 544 | 0.050 |
Why?
|
| Young Adult | 6 | 2018 | 21445 | 0.050 |
Why?
|
| Electrodes | 1 | 2002 | 116 | 0.050 |
Why?
|
| Oxygenators | 1 | 2001 | 3 | 0.050 |
Why?
|
| Treatment Failure | 3 | 2016 | 1391 | 0.050 |
Why?
|
| Pyrrolidines | 2 | 2000 | 113 | 0.050 |
Why?
|
| Heart Bypass, Left | 1 | 2001 | 15 | 0.050 |
Why?
|
| Caco-2 Cells | 2 | 1999 | 158 | 0.050 |
Why?
|
| Personality | 1 | 2023 | 116 | 0.050 |
Why?
|
| Decontamination | 1 | 2021 | 16 | 0.050 |
Why?
|
| Clinical Protocols | 2 | 2014 | 467 | 0.050 |
Why?
|
| Leg | 2 | 2003 | 226 | 0.050 |
Why?
|
| Diagnosis, Differential | 2 | 2009 | 4744 | 0.050 |
Why?
|
| Pulmonary Embolism | 1 | 2004 | 329 | 0.050 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2021 | 208 | 0.050 |
Why?
|
| Imaging, Three-Dimensional | 2 | 2004 | 925 | 0.050 |
Why?
|
| Ventricular Function | 2 | 1998 | 93 | 0.050 |
Why?
|
| Students | 1 | 2023 | 324 | 0.050 |
Why?
|
| Men | 1 | 2020 | 9 | 0.050 |
Why?
|
| Dermatan Sulfate | 1 | 2000 | 4 | 0.050 |
Why?
|
| Kidney | 2 | 2006 | 2146 | 0.050 |
Why?
|
| Intensive Care Units | 2 | 2015 | 717 | 0.050 |
Why?
|
| Genetic Carrier Screening | 1 | 2000 | 92 | 0.050 |
Why?
|
| Decision Trees | 1 | 2000 | 178 | 0.050 |
Why?
|
| Heparitin Sulfate | 1 | 2000 | 35 | 0.050 |
Why?
|
| Kidney Transplantation | 1 | 2006 | 755 | 0.050 |
Why?
|
| Multimodal Imaging | 1 | 2024 | 550 | 0.040 |
Why?
|
| Cardiovascular Agents | 1 | 2021 | 128 | 0.040 |
Why?
|
| Research Personnel | 1 | 2021 | 156 | 0.040 |
Why?
|
| Tosyllysine Chloromethyl Ketone | 1 | 1999 | 2 | 0.040 |
Why?
|
| Survivors | 1 | 2005 | 1031 | 0.040 |
Why?
|
| Leupeptins | 1 | 1999 | 68 | 0.040 |
Why?
|
| Anesthetics, Combined | 1 | 1999 | 14 | 0.040 |
Why?
|
| Dilatation, Pathologic | 3 | 2004 | 88 | 0.040 |
Why?
|
| Hydrogen Peroxide | 1 | 2000 | 217 | 0.040 |
Why?
|
| Neonatal Screening | 1 | 2000 | 165 | 0.040 |
Why?
|
| Perception | 1 | 2021 | 350 | 0.040 |
Why?
|
| Genistein | 1 | 1999 | 73 | 0.040 |
Why?
|
| Odds Ratio | 2 | 2014 | 2316 | 0.040 |
Why?
|
| Isoflurane | 1 | 1999 | 67 | 0.040 |
Why?
|
| Esophageal Neoplasms | 1 | 1992 | 3168 | 0.040 |
Why?
|
| Data Collection | 1 | 2021 | 620 | 0.040 |
Why?
|
| Heat-Shock Response | 1 | 1998 | 40 | 0.040 |
Why?
|
| Mammary Arteries | 2 | 2012 | 64 | 0.040 |
Why?
|
| Gelatin Sponge, Absorbable | 1 | 2018 | 9 | 0.040 |
Why?
|
| Statistics, Nonparametric | 2 | 2013 | 980 | 0.040 |
Why?
|
| Uncertainty | 1 | 2020 | 320 | 0.040 |
Why?
|
| Intermittent Claudication | 1 | 1998 | 56 | 0.040 |
Why?
|
| Positron Emission Tomography Computed Tomography | 1 | 2024 | 833 | 0.040 |
Why?
|
| Fluorodeoxyglucose F18 | 1 | 2024 | 1226 | 0.040 |
Why?
|
| Analgesics | 1 | 2021 | 390 | 0.040 |
Why?
|
| Hemostasis, Surgical | 1 | 2018 | 48 | 0.040 |
Why?
|
| Tissue Adhesives | 1 | 2018 | 51 | 0.040 |
Why?
|
| Congenital Abnormalities | 1 | 2000 | 260 | 0.040 |
Why?
|
| Acid-Base Equilibrium | 1 | 2017 | 78 | 0.040 |
Why?
|
| Anti-Bacterial Agents | 3 | 2007 | 2992 | 0.040 |
Why?
|
| Tissue Engineering | 1 | 2020 | 269 | 0.040 |
Why?
|
| Cross-Linking Reagents | 1 | 2018 | 153 | 0.040 |
Why?
|
| Registries | 2 | 2015 | 2170 | 0.040 |
Why?
|
| Neoplasms | 1 | 2023 | 15193 | 0.040 |
Why?
|
| Torsion Abnormality | 2 | 1994 | 38 | 0.040 |
Why?
|
| Action Potentials | 1 | 2020 | 560 | 0.040 |
Why?
|
| Feasibility Studies | 2 | 2012 | 2292 | 0.040 |
Why?
|
| Statistics as Topic | 2 | 2012 | 445 | 0.040 |
Why?
|
| Antibodies | 1 | 2020 | 838 | 0.040 |
Why?
|
| Surveys and Questionnaires | 2 | 2020 | 5687 | 0.040 |
Why?
|
| Regional Blood Flow | 1 | 2017 | 276 | 0.040 |
Why?
|
| Intersectoral Collaboration | 1 | 2016 | 44 | 0.040 |
Why?
|
| Rheumatic Heart Disease | 1 | 2017 | 44 | 0.040 |
Why?
|
| Disease-Free Survival | 2 | 2015 | 10001 | 0.040 |
Why?
|
| Respiration | 1 | 1999 | 447 | 0.040 |
Why?
|
| DNA Primers | 1 | 1999 | 1399 | 0.040 |
Why?
|
| Genetic Diseases, Inborn | 1 | 2000 | 442 | 0.040 |
Why?
|
| Operative Time | 1 | 2016 | 217 | 0.030 |
Why?
|
| Creatine Kinase, MB Form | 1 | 2015 | 29 | 0.030 |
Why?
|
| Computed Tomography Angiography | 1 | 2017 | 234 | 0.030 |
Why?
|
| Lung Transplantation | 1 | 2000 | 359 | 0.030 |
Why?
|
| Models, Structural | 1 | 1995 | 103 | 0.030 |
Why?
|
| Interleukin-1 Receptor-Like 1 Protein | 1 | 2015 | 30 | 0.030 |
Why?
|
| Thrombosis | 3 | 2000 | 781 | 0.030 |
Why?
|
| Iliac Artery | 2 | 2010 | 108 | 0.030 |
Why?
|
| Infusions, Intravenous | 3 | 2006 | 1382 | 0.030 |
Why?
|
| Adenocarcinoma | 2 | 2000 | 7789 | 0.030 |
Why?
|
| Graft Survival | 2 | 2012 | 1062 | 0.030 |
Why?
|
| Polynucleotides | 1 | 1994 | 11 | 0.030 |
Why?
|
| North America | 1 | 2015 | 314 | 0.030 |
Why?
|
| Computer-Assisted Instruction | 1 | 2015 | 81 | 0.030 |
Why?
|
| Papillary Muscles | 1 | 1994 | 27 | 0.030 |
Why?
|
| Interdisciplinary Communication | 1 | 2016 | 280 | 0.030 |
Why?
|
| Patient Safety | 1 | 2020 | 649 | 0.030 |
Why?
|
| Postoperative Period | 2 | 1994 | 665 | 0.030 |
Why?
|
| Health Services Needs and Demand | 1 | 2016 | 244 | 0.030 |
Why?
|
| Hydroxybutyrates | 1 | 1994 | 44 | 0.030 |
Why?
|
| Diabetic Angiopathies | 1 | 2015 | 78 | 0.030 |
Why?
|
| Methoxamine | 1 | 1994 | 3 | 0.030 |
Why?
|
| Models, Anatomic | 1 | 2015 | 154 | 0.030 |
Why?
|
| Primary Health Care | 1 | 2000 | 787 | 0.030 |
Why?
|
| Polyesters | 1 | 1994 | 53 | 0.030 |
Why?
|
| Thrombin | 1 | 1994 | 99 | 0.030 |
Why?
|
| Dobutamine | 1 | 1994 | 54 | 0.030 |
Why?
|
| Policy Making | 1 | 2014 | 85 | 0.030 |
Why?
|
| Cytokines | 2 | 2003 | 2809 | 0.030 |
Why?
|
| Educational Status | 1 | 2015 | 397 | 0.030 |
Why?
|
| Tissue Adhesions | 1 | 1994 | 60 | 0.030 |
Why?
|
| Heart Defects, Congenital | 1 | 2005 | 1697 | 0.030 |
Why?
|
| Transfection | 1 | 1999 | 2944 | 0.030 |
Why?
|
| Biomarkers | 2 | 2015 | 5047 | 0.030 |
Why?
|
| Troponin T | 1 | 2015 | 261 | 0.030 |
Why?
|
| Communication | 1 | 2020 | 876 | 0.030 |
Why?
|
| Video Recording | 1 | 2015 | 267 | 0.030 |
Why?
|
| Normal Distribution | 1 | 2013 | 61 | 0.030 |
Why?
|
| Interleukin-6 | 1 | 1998 | 1038 | 0.030 |
Why?
|
| Sodium Chloride | 1 | 1994 | 156 | 0.030 |
Why?
|
| Oligonucleotides | 1 | 1994 | 227 | 0.030 |
Why?
|
| Cesarean Section | 1 | 2016 | 367 | 0.030 |
Why?
|
| Laryngeal Nerve Injuries | 1 | 1992 | 2 | 0.030 |
Why?
|
| Program Development | 1 | 2014 | 261 | 0.030 |
Why?
|
| Horner Syndrome | 1 | 1992 | 12 | 0.030 |
Why?
|
| Pregnancy Outcome | 1 | 2016 | 643 | 0.030 |
Why?
|
| Patient Acuity | 1 | 2012 | 72 | 0.030 |
Why?
|
| Hematoma | 1 | 1993 | 160 | 0.030 |
Why?
|
| Base Sequence | 1 | 1999 | 4917 | 0.030 |
Why?
|
| Postoperative Care | 2 | 2013 | 739 | 0.030 |
Why?
|
| Echocardiography, Doppler | 2 | 2009 | 180 | 0.030 |
Why?
|
| Gene Expression Regulation | 1 | 2003 | 4053 | 0.030 |
Why?
|
| RNA, Messenger | 2 | 1999 | 6150 | 0.030 |
Why?
|
| Learning | 1 | 2015 | 403 | 0.030 |
Why?
|
| Prostheses and Implants | 1 | 1994 | 295 | 0.030 |
Why?
|
| Washington | 1 | 2011 | 70 | 0.030 |
Why?
|
| Guideline Adherence | 1 | 2016 | 636 | 0.020 |
Why?
|
| Motor Activity | 1 | 2015 | 693 | 0.020 |
Why?
|
| Ultrasonography, Doppler | 1 | 2012 | 231 | 0.020 |
Why?
|
| Pediatrics | 1 | 2000 | 1141 | 0.020 |
Why?
|
| Biopsy | 1 | 2019 | 3443 | 0.020 |
Why?
|
| Endoleak | 1 | 2010 | 17 | 0.020 |
Why?
|
| Morbidity | 2 | 2006 | 397 | 0.020 |
Why?
|
| Reference Values | 2 | 2007 | 1099 | 0.020 |
Why?
|
| Heart Arrest | 1 | 2014 | 358 | 0.020 |
Why?
|
| Contrast Media | 1 | 2016 | 1472 | 0.020 |
Why?
|
| Socioeconomic Factors | 1 | 2013 | 1225 | 0.020 |
Why?
|
| Ambulatory Care | 1 | 2013 | 554 | 0.020 |
Why?
|
| Cognition | 1 | 2015 | 968 | 0.020 |
Why?
|
| Pericardiectomy | 1 | 2008 | 6 | 0.020 |
Why?
|
| Models, Theoretical | 2 | 2008 | 785 | 0.020 |
Why?
|
| Obesity | 1 | 2021 | 2884 | 0.020 |
Why?
|
| Recombinant Proteins | 2 | 2007 | 2927 | 0.020 |
Why?
|
| Pneumonia | 1 | 2014 | 751 | 0.020 |
Why?
|
| Child | 2 | 2018 | 29154 | 0.020 |
Why?
|
| Respiration, Artificial | 1 | 2011 | 577 | 0.020 |
Why?
|
| Tomography, Spiral Computed | 1 | 2008 | 133 | 0.020 |
Why?
|
| Confidence Intervals | 1 | 2009 | 756 | 0.020 |
Why?
|
| Intraoperative Period | 1 | 2006 | 246 | 0.020 |
Why?
|
| Sex Distribution | 1 | 2007 | 495 | 0.020 |
Why?
|
| Age Distribution | 1 | 2007 | 698 | 0.020 |
Why?
|
| Primary Prevention | 1 | 2007 | 255 | 0.020 |
Why?
|
| Linear Models | 1 | 2007 | 1085 | 0.020 |
Why?
|
| Heparin, Low-Molecular-Weight | 1 | 2005 | 66 | 0.020 |
Why?
|
| Pulsatile Flow | 1 | 2005 | 131 | 0.020 |
Why?
|
| Lymphotoxin-beta | 1 | 2003 | 3 | 0.010 |
Why?
|
| Radiography, Interventional | 1 | 2006 | 305 | 0.010 |
Why?
|
| Lymphotoxin-alpha | 1 | 2003 | 27 | 0.010 |
Why?
|
| Uracil-DNA Glycosidase | 1 | 2003 | 25 | 0.010 |
Why?
|
| Cerebrovascular Circulation | 1 | 2007 | 471 | 0.010 |
Why?
|
| N-Glycosyl Hydrolases | 1 | 2003 | 47 | 0.010 |
Why?
|
| Central Venous Pressure | 1 | 2003 | 28 | 0.010 |
Why?
|
| Natriuresis | 1 | 2003 | 43 | 0.010 |
Why?
|
| Intraoperative Care | 1 | 2004 | 259 | 0.010 |
Why?
|
| Mesenteric Vascular Occlusion | 1 | 2003 | 18 | 0.010 |
Why?
|
| DNA Fingerprinting | 1 | 2003 | 167 | 0.010 |
Why?
|
| Receptors, Tumor Necrosis Factor | 1 | 2003 | 184 | 0.010 |
Why?
|
| Pregnancy | 1 | 2016 | 7573 | 0.010 |
Why?
|
| Transcription, Genetic | 2 | 2003 | 3154 | 0.010 |
Why?
|
| Vascular Resistance | 1 | 2003 | 200 | 0.010 |
Why?
|
| Fatal Outcome | 1 | 2004 | 829 | 0.010 |
Why?
|
| Preanesthetic Medication | 1 | 2001 | 9 | 0.010 |
Why?
|
| Vasodilation | 1 | 2003 | 205 | 0.010 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2003 | 198 | 0.010 |
Why?
|
| DNA, Complementary | 1 | 2003 | 869 | 0.010 |
Why?
|
| Radiology, Interventional | 1 | 2003 | 138 | 0.010 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2005 | 444 | 0.010 |
Why?
|
| Hypotension | 1 | 2003 | 210 | 0.010 |
Why?
|
| Drug Therapy, Combination | 1 | 2006 | 2315 | 0.010 |
Why?
|
| Suppuration | 1 | 2000 | 5 | 0.010 |
Why?
|
| Cell Adhesion Molecules | 1 | 2003 | 577 | 0.010 |
Why?
|
| Heart-Lung Transplantation | 1 | 2000 | 24 | 0.010 |
Why?
|
| Immunosuppressive Agents | 1 | 2006 | 1375 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2009 | 4971 | 0.010 |
Why?
|
| Extracellular Matrix | 1 | 2003 | 554 | 0.010 |
Why?
|
| Bronchiectasis | 1 | 2000 | 26 | 0.010 |
Why?
|
| Oxidants | 1 | 2000 | 49 | 0.010 |
Why?
|
| Dimethyl Sulfoxide | 1 | 2000 | 52 | 0.010 |
Why?
|
| Diagnostic Errors | 1 | 2004 | 509 | 0.010 |
Why?
|
| Free Radical Scavengers | 1 | 2000 | 80 | 0.010 |
Why?
|
| Demography | 1 | 2000 | 435 | 0.010 |
Why?
|
| Research Design | 1 | 2006 | 1544 | 0.010 |
Why?
|
| Pulse | 1 | 1998 | 31 | 0.010 |
Why?
|
| Protein Kinases | 1 | 2003 | 874 | 0.010 |
Why?
|
| Cardiac Volume | 1 | 1998 | 18 | 0.010 |
Why?
|
| Mutation | 1 | 1999 | 15179 | 0.010 |
Why?
|
| Endarterectomy | 1 | 1998 | 25 | 0.010 |
Why?
|
| Anesthetics, Inhalation | 1 | 1999 | 62 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 1999 | 4938 | 0.010 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2006 | 2594 | 0.010 |
Why?
|
| Remission Induction | 1 | 2004 | 3569 | 0.010 |
Why?
|
| Intraoperative Complications | 1 | 2000 | 301 | 0.010 |
Why?
|
| Muscle Fibers, Skeletal | 1 | 1998 | 116 | 0.010 |
Why?
|
| Drug Combinations | 1 | 2000 | 621 | 0.010 |
Why?
|
| Saphenous Vein | 1 | 1998 | 95 | 0.010 |
Why?
|
| Polytetrafluoroethylene | 1 | 1998 | 113 | 0.010 |
Why?
|
| HSP70 Heat-Shock Proteins | 1 | 1998 | 161 | 0.010 |
Why?
|
| Hot Temperature | 1 | 1998 | 281 | 0.010 |
Why?
|
| Cystic Fibrosis | 1 | 2000 | 264 | 0.010 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2003 | 2508 | 0.010 |
Why?
|
| Transplantation, Autologous | 1 | 2001 | 1914 | 0.010 |
Why?
|
| Neoplasm Staging | 1 | 1992 | 13658 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2003 | 3639 | 0.010 |
Why?
|
| Cardiomyopathy, Hypertrophic | 1 | 1998 | 192 | 0.010 |
Why?
|
| Antioxidants | 1 | 2000 | 507 | 0.010 |
Why?
|
| In Vitro Techniques | 1 | 1998 | 1618 | 0.010 |
Why?
|
| Blood Volume | 1 | 1996 | 100 | 0.010 |
Why?
|
| Transportation of Patients | 1 | 1996 | 59 | 0.010 |
Why?
|
| Prothrombin Time | 1 | 1994 | 44 | 0.010 |
Why?
|
| Thrombocytopenia | 1 | 2000 | 846 | 0.010 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 1994 | 220 | 0.010 |
Why?
|
| Electroencephalography | 1 | 1999 | 898 | 0.010 |
Why?
|
| Cell Nucleus | 1 | 2000 | 1620 | 0.010 |
Why?
|
| Aptamers, Nucleotide | 1 | 1994 | 62 | 0.010 |
Why?
|
| Tissue Donors | 1 | 1998 | 769 | 0.010 |
Why?
|
| Cell Survival | 1 | 2000 | 3045 | 0.010 |
Why?
|
| Double-Blind Method | 1 | 1999 | 2588 | 0.010 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 1994 | 548 | 0.010 |
Why?
|
| Consciousness | 1 | 1993 | 56 | 0.010 |
Why?
|
| Biocompatible Materials | 1 | 1994 | 202 | 0.010 |
Why?
|
| Membrane Proteins | 1 | 2003 | 2819 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 2000 | 5395 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 1998 | 3203 | 0.010 |
Why?
|
| Cattle | 1 | 1993 | 783 | 0.010 |
Why?
|
| Colonic Neoplasms | 1 | 2000 | 1390 | 0.010 |
Why?
|
| Random Allocation | 1 | 1993 | 703 | 0.010 |
Why?
|
| Gene Expression Profiling | 1 | 2003 | 5159 | 0.010 |
Why?
|
| Antihypertensive Agents | 1 | 1993 | 395 | 0.010 |
Why?
|
| Collagen | 1 | 1994 | 752 | 0.010 |
Why?
|
| Endothelium, Vascular | 1 | 1994 | 891 | 0.010 |
Why?
|
| Emergency Service, Hospital | 1 | 1996 | 1148 | 0.000 |
Why?
|
| Transcription Factors | 1 | 2000 | 5270 | 0.000 |
Why?
|